ANI PHARMACEUTICALS INC (ANIP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 100M 200M 300M Q1 '10: 2.3M Q2 '10: 0 Q3 '10: 51.3K Q4 '10: 143K Q1 '11: 57K Q2 '11: 81K Q3 '11: 182.8K Q4 '11: 114.4K Q1 '12: 114K Q2 '12: 5.2M Q3 '12: 5M Q4 '12: 2M Q1 '13: 5.6M Q2 '13: 6.2M Q3 '13: 7.8M Q4 '13: 10.5M Q1 '14: 10.9M Q2 '14: 6.6M Q3 '14: 17.4M Q4 '14: 21M Q1 '15: 18.8M Q2 '15: 19.5M Q3 '15: 20M Q4 '15: 18M Q1 '16: 20.6M Q2 '16: 31.3M Q3 '16: 38.5M Q4 '16: 38.2M Q1 '17: 36.6M Q2 '17: 44.8M Q2 '17: 44.8M Q3 '17: 48.2M Q4 '17: 47.3M Q1 '18: 46.5M Q2 '18: 47.3M Q3 '18: 50.7M Q4 '18: 57.1M Q1 '19: 52.9M Q2 '19: 54.4M Q3 '19: 51.3M Q4 '19: 48M Q1 '20: 49.8M Q2 '20: 48.5M Q3 '20: 53M Q4 '20: 57.3M Q1 '21: 54.5M Q2 '21: 48.6M Q3 '21: 52.1M Q4 '21: 60.9M Q1 '22: 64.5M Q2 '22: 73.9M Q3 '22: 83.8M Q4 '22: 94.2M Q1 '23: 106.8M Q2 '23: 116.5M Q3 '23: 131.8M Q4 '23: 131.7M Q1 '24: 137.4M Q2 '24: 138M Q3 '24: 148.3M Q4 '24: 190.6M Q1 '25: 197.1M Q2 '25: 211.4M Q3 '25: 227.8M Q4 '25: 247.1M Q1 '26: 237.5M Q2 '26: 266M Q4 '10 Q1 '13 Q2 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Gross Profit Quarterly

0 50M 100M 150M Q1 '20: 16.8M Q2 '20: 16.6M Q3 '20: 21.5M Q4 '20: 21.8M Q1 '21: 23.6M Q2 '21: 15M Q3 '21: 16.3M Q4 '21: 13.3M Q1 '22: 15.6M Q2 '22: 24.8M Q3 '22: 36.8M Q4 '22: 43.4M Q1 '23: 54.4M Q2 '23: 59.6M Q3 '23: 68.5M Q4 '23: 63M Q1 '24: 73.6M Q2 '24: 65.6M Q3 '24: 69.5M Q4 '24: 87.7M Q1 '25: 101.2M Q2 '25: 113.5M Q3 '25: 111.8M Q4 '25: 124.2M Q1 '26: 123M Q2 '26: 146.2M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-30M -15M 0 15M 30M 45M Q1 '10: -9M Q2 '10: -10.2M Q3 '10: -11.2M Q4 '10: -13.2M Q1 '11: -16.4M Q2 '11: -13.1M Q3 '11: -13M Q4 '11: -8.3M Q1 '12: -6.9M Q2 '12: 586.4K Q3 '12: -207.4K Q4 '12: -3.6M Q1 '13: 403K Q2 '13: -3.8M Q3 '13: 810K Q1 '14: 3.5M Q2 '14: -2.5M Q3 '14: 8.2M Q4 '14: 10.8M Q1 '15: 9.6M Q2 '15: 8.4M Q3 '15: 8.5M Q4 '15: 6.3M Q1 '16: 5.7M Q2 '16: 5.2M Q3 '16: 7.9M Q4 '16: 1.3M Q1 '17: 4.6M Q2 '17: 7M Q2 '17: 7M Q3 '17: 9.3M Q4 '17: 7.4M Q1 '18: 6.5M Q2 '18: 7.3M Q3 '18: 10.1M Q4 '18: 11.4M Q1 '19: 4.4M Q2 '19: 9.3M Q3 '19: 7.3M Q4 '19: -4.7M Q1 '20: -7.8M Q2 '20: -11.3M Q3 '20: 2.8M Q4 '20: 331K Q1 '21: 3M Q2 '21: -15.6M Q3 '21: -3.6M Q4 '21: -23.7M Q1 '22: -19.2M Q2 '22: -12.9M Q3 '22: -5M Q4 '22: 1.8M Q1 '23: 9.9M Q2 '23: 12.4M Q3 '23: 17.9M Q4 '23: 6.7M Q1 '24: 20.3M Q2 '24: 5.2M Q3 '24: -20.5M Q4 '24: -4.4M Q1 '25: 26.2M Q2 '25: 13.9M Q3 '25: 36.2M Q4 '25: 34.8M Q1 '26: 38.9M Q2 '26: 40.5M Q3 '10 Q4 '12 Q2 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income Quarterly

-30M -15M 0 15M 30M 45M Q1 '10: -10.5M Q2 '10: -10.8M Q3 '10: -11.6M Q4 '10: -13.3M Q1 '11: -17.3M Q2 '11: -15M Q3 '11: -12.7M Q4 '11: -6.6M Q1 '12: -10.3M Q2 '12: 35.4K Q3 '12: -377.3K Q4 '12: -1.2M Q1 '13: 260K Q2 '13: -4.6M Q3 '13: 1.2M Q4 '13: 3.4M Q1 '14: 3.4M Q2 '14: -2.4M Q3 '14: 6.7M Q4 '14: 21M Q1 '15: 4.4M Q2 '15: 3.6M Q3 '15: 4.6M Q4 '15: 2.9M Q1 '16: 1.3M Q2 '16: 1.1M Q3 '16: 2.5M Q1 '17: 1.2M Q2 '17: 2.7M Q2 '17: 2.7M Q3 '17: 4.7M Q1 '18: 2.2M Q2 '18: 2.8M Q3 '18: 5M Q4 '18: 5.4M Q1 '19: 449K Q2 '19: 6.6M Q3 '19: 3.9M Q4 '19: -4.8M Q1 '20: -7M Q2 '20: -12.3M Q3 '20: 434K Q4 '20: -3.6M Q1 '21: 86K Q2 '21: -14.1M Q3 '21: -4.4M Q4 '21: -24.1M Q1 '22: -20.1M Q2 '22: -14.9M Q3 '22: -8.6M Q4 '22: -4.2M Q1 '23: 1.4M Q2 '23: 6.2M Q3 '23: 9.9M Q4 '23: 1.2M Q1 '24: 18.2M Q2 '24: -2.3M Q3 '24: -24.2M Q4 '24: -10.3M Q1 '25: 15.7M Q2 '25: 8.5M Q3 '25: 26.6M Q4 '25: 27.5M Q1 '26: 29.5M Q2 '26: 24.7M Q2 '10 Q3 '12 Q4 '14 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 35M 70M 105M Q1 '12: 1.9M Q2 '12: 2.1M Q3 '12: 2.3M Q4 '12: 2.9M Q1 '13: 2.4M Q2 '13: 2.2M Q3 '13: 2.7M Q4 '13: 2.7M Q1 '14: 2.6M Q2 '14: 2.1M Q3 '14: 3.1M Q4 '14: 3.7M Q1 '15: 2.8M Q2 '15: 3.1M Q3 '15: 3.3M Q4 '15: 3.5M Q1 '16: 3.4M Q2 '16: 11.8M Q3 '16: 16.7M Q4 '16: 16.9M Q1 '17: 16.4M Q2 '17: 21.1M Q2 '17: 21.1M Q3 '17: 21.1M Q4 '17: 20.4M Q1 '18: 20.7M Q2 '18: 16.6M Q3 '18: 15.6M Q4 '18: 20.1M Q1 '19: 14.7M Q2 '19: 15.6M Q3 '19: 15M Q4 '19: 17.8M Q1 '20: 21.8M Q2 '20: 20.7M Q3 '20: 20.1M Q4 '20: 24.5M Q1 '21: 20M Q2 '21: 22.3M Q3 '21: 24.4M Q4 '21: 33.9M Q1 '22: 34.3M Q2 '22: 35.3M Q3 '22: 32.9M Q4 '22: 36.3M Q1 '23: 37.7M Q2 '23: 42.3M Q3 '23: 48.1M Q4 '23: 53.4M Q1 '24: 49.2M Q2 '24: 57.7M Q3 '24: 63.1M Q4 '24: 80.3M Q1 '25: 73M Q2 '25: 74.6M Q3 '25: 93.4M Q4 '25: 100.3M Q1 '26: 93.6M Q2 '26: 100.2M Q3 '12 Q3 '14 Q3 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating Cash Flow Quarterly

-30M 0 30M 60M 90M Q3 '10: -10.9M Q1 '11: -10.5M Q2 '11: -13.9M Q3 '11: -12.6M Q4 '11: -10.9M Q1 '12: -7.7M Q2 '12: 8.3M Q3 '12: -134.3K Q4 '12: -609.2K Q1 '13: -234K Q2 '13: -754K Q3 '13: -1.6M Q4 '13: -2.9M Q1 '14: 5.2M Q2 '14: 2M Q3 '14: 4.2M Q4 '14: 10.7M Q1 '15: 1.1M Q2 '15: 1.2M Q3 '15: 10.2M Q4 '15: 4.7M Q1 '16: 11M Q2 '16: 3.3M Q3 '16: 1.1M Q4 '16: 12.1M Q1 '17: 6.5M Q2 '17: 1K Q3 '17: 17.1M Q4 '17: 15.8M Q1 '18: 22.9M Q2 '18: 8.6M Q3 '18: 8.3M Q4 '18: 27.2M Q1 '19: 14.3M Q2 '19: 4.7M Q3 '19: 21.8M Q4 '19: 4.8M Q1 '20: 1.7M Q2 '20: 20.9M Q3 '20: -1.6M Q4 '20: -5.7M Q1 '21: 20.7M Q2 '21: 241K Q3 '21: -5.4M Q4 '21: -12.2M Q1 '22: -18.9M Q2 '22: -11.5M Q3 '22: 3.6M Q4 '22: -4.4M Q1 '23: 21.4M Q2 '23: 20.6M Q3 '23: 32.2M Q4 '23: 44.7M Q1 '24: 18.3M Q2 '24: 17.4M Q3 '24: 12.5M Q4 '24: 15.9M Q1 '25: 35M Q2 '25: 75.8M Q3 '25: 44.1M Q4 '25: 30.4M Q1 '26: 58.4M Q2 '26: 56.7M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-25M 0 25M 50M 75M Q3 '10: -10.9M Q1 '11: -10.7M Q2 '11: -14.2M Q3 '11: -12.7M Q4 '11: -11M Q1 '12: -7.7M Q2 '12: 8.3M Q3 '12: -142.1K Q4 '12: -824.3K Q1 '13: -342K Q2 '13: -774K Q3 '13: -1.7M Q4 '13: -2.9M Q1 '14: 5.1M Q2 '14: 1.7M Q3 '14: 3.7M Q4 '14: 10.4M Q1 '15: 1M Q2 '15: 1M Q3 '15: 9.5M Q4 '15: 3.6M Q1 '16: 9.6M Q2 '16: 2.6M Q3 '16: -5K Q4 '16: 10.7M Q1 '17: 4.4M Q2 '17: -2.3M Q3 '17: 14.6M Q4 '17: 12.4M Q1 '18: 20.7M Q2 '18: 7.5M Q3 '18: 6.9M Q4 '18: 26.2M Q1 '19: 12.5M Q2 '19: 3.1M Q3 '19: 20.3M Q4 '19: 3.1M Q1 '20: 171K Q2 '20: 20.2M Q3 '20: -3.4M Q4 '20: -7.8M Q1 '21: 20M Q2 '21: -691K Q3 '21: -6M Q4 '21: -12.5M Q1 '22: -20.9M Q2 '22: -12.8M Q3 '22: 1.2M Q4 '22: -7.5M Q1 '23: 19.1M Q2 '23: 18.1M Q3 '23: 30.4M Q4 '23: 42.5M Q1 '24: 13.7M Q2 '24: 13M Q3 '24: 7.7M Q4 '24: 13.5M Q1 '25: 32.5M Q2 '25: 71.8M Q3 '25: 38M Q4 '25: 29.1M Q1 '26: 52.3M Q2 '26: 53.6M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q2 '10: 64.6M Q3 '10: 71.2M Q1 '11: 84.8M Q2 '11: 15.7M Q3 '11: 17.4M Q1 '12: 116.3M Q2 '12: 20.2M Q3 '12: 22.9M Q1 '13: 0 Q2 '13: 1.2M Q3 '13: 9.5M Q1 '14: 10M Q2 '14: 11.2M Q3 '14: 11.3M Q1 '15: 11.6M Q2 '15: 11.5M Q3 '15: 11.6M Q1 '16: 11.5M Q2 '16: 11.5M Q3 '16: 11.6M Q1 '17: 11.7M Q2 '17: 11.7M Q2 '17: 11.7M Q3 '17: 11.7M Q1 '18: 11.7M Q2 '18: 11.8M Q3 '18: 11.8M Q1 '19: 11.8M Q2 '19: 12.3M Q3 '19: 12.1M Q1 '20: 11.9M Q2 '20: 12M Q3 '20: 12M Q1 '21: 12M Q2 '21: 12.1M Q3 '21: 12.1M Q1 '22: 16.1M Q2 '22: 16.3M Q3 '22: 16.3M Q1 '23: 16.5M Q2 '23: 17.9M Q3 '23: 19.1M Q1 '24: 19.4M Q2 '24: 19.3M Q3 '24: 19.4M Q1 '25: 20M Q2 '25: 20.3M Q3 '25: 21.1M Q1 '26: 21.5M Q2 '26: 21.9M Q2 '10 Q3 '12 Q1 '15 Q2 '17 Q2 '19 Q3 '21 Q1 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q4 '10: -2.55 Q1 '11: -1.61 Q3 '13: -6.06 Q4 '14: 2.53 Q1 '15: 2.58 Q2 '15: 3.10 Q3 '15: 2.90 Q4 '15: 1.33 Q1 '16: 1.07 Q2 '16: 0.86 Q3 '16: 0.69 Q4 '16: 0.35 Q1 '17: 0.33 Q2 '17: 0.46 Q1 '18: -0.01 Q2 '18: -0.01 Q3 '18: 0.01 Q4 '18: 1.30 Q1 '19: 1.15 Q2 '19: 1.45 Q3 '19: 1.35 Q4 '19: 0.48 Q1 '20: -0.15 Q2 '20: -1.71 Q3 '20: -1.99 Q4 '20: -1.88 Q1 '21: -1.28 Q2 '21: -1.42 Q3 '21: -1.83 Q4 '21: -3.40 Q1 '22: -4.68 Q2 '22: -4.45 Q3 '22: -4.63 Q4 '22: -3.05 Q1 '23: -1.72 Q2 '23: -0.49 Q3 '23: 0.51 Q4 '23: 0.82 Q1 '24: 1.58 Q2 '24: 1.15 Q3 '24: -0.57 Q4 '24: -1.14 Q1 '25: -1.27 Q2 '25: -0.77 Q3 '25: 1.63 Q4 '25: 3.35 Q1 '26: 3.94 Q2 '26: 4.63 Q2 '15 Q4 '16 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.